The impact of COVID-19 on clinical research: the PIPPRA and MEDRA experience.
Louise LarkinTala RaadAnusha MosesAlexander FraserStephen GallagherBente Appel EsbensenLiam G GlynnAnne Christina GriffinAudrey C TierneyNorelee M KennedyPublished in: HRB open research (2023)
The COVID-19 pandemic has severely impacted the PIPPRA and MEDRA clinical trials. Moving face-to-face clinical research to telehealth delivery may not be the panacea it is purported to be. Our experiences may be of benefit to researchers, clinicians, and funders in seeking to continue clinical research during a global pandemic.